Cerebrospinal fluid soluble TREM2 in aging and Alzheimer’s disease

BACKGROUND: Alzheimer’s disease (AD) neuropathology is associated with neuroinflammation, but there are few useful biomarkers. Mutant variants of triggering receptor expressed on myeloid cells 2 (TREM2) have recently been linked to late-onset AD and other neurodegenerative disorders. TREM2, a microg...

Descripción completa

Detalles Bibliográficos
Autores principales: Henjum, Kristi, Almdahl, Ina S., Årskog, Vibeke, Minthon, Lennart, Hansson, Oskar, Fladby, Tormod, Nilsson, Lars N. G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4848774/
https://www.ncbi.nlm.nih.gov/pubmed/27121148
http://dx.doi.org/10.1186/s13195-016-0182-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4848774/
https://www.ncbi.nlm.nih.gov/pubmed/27121148
http://dx.doi.org/10.1186/s13195-016-0182-1

Ejemplares similares